Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
3741
Clinicopathological characteristics and survival outcomes of women aged ≤45 and >45 years with endometrial adenocarcinoma in tertiary referral hospital: a 21-year cohort study
Published 2025-01-01“…Objective This study aimed to compare clinicopathological characteristics and oncological outcomes in patients with endometrial cancer aged ≤45 and >45 years, with a focus on identifying distinct traits and prognostic factors in younger patients.Design A retrospective cohort study.Setting The study was conducted at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, with a restricted study population from 1996 to 2016.Participants A total of 1114 patients diagnosed with endometrial cancer and underwent surgery were strictly selected, excluding those who had received primary radiotherapy or had uterine sarcoma. …”
Get full text
Article -
3742
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Published 2025-01-01Get full text
Article -
3743
Surgical margins of the oral cavity: is 5 mm really necessary?
Published 2022-10-01Get full text
Article -
3744
-
3745
Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
Published 2024-09-01Get full text
Article -
3746
-
3747
-
3748
-
3749
-
3750
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
3751
-
3752
Dynamin-1 is a potential mediator in cancer-related cognitive impairment
Published 2025-01-01Get full text
Article -
3753
Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis
Published 2024-11-01“…This retrospective cross-sectional study included 207 paediatric oncology patients treated for nephroblastoma at the Paediatric Haematology and Oncology Unit at UAHC, Bloemfontein, SA, from January 2000 to December 2020. …”
Get full text
Article -
3754
-
3755
Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer
Published 2012-01-01Get full text
Article -
3756
-
3757
-
3758
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
Published 2025-01-01Get full text
Article -
3759
-
3760
NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome
Published 2025-01-01Get full text
Article